We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Stryker Worldwide

evelops medical products and technologies, including Implants (joint replacement), Trauma, Craniomaxillofacial, Spina... read more Featured Products: More products

Download Mobile App




Ultrasonic Technology Augments Soft Tissue Fixation

By HospiMedica International staff writers
Posted on 10 Aug 2016
A new bioresorbable implant utilizes ultrasonic energy to liquefy and flow into cancellous bone to provide stable soft tissue to bone fixation.

The Stryker (Kalamazoo, MI, USA) SonicAnchor is a bioresorbable implant made of poly-L-DL-lactic acid (PLDLLA), which is placed into a hole drilled into the cancellous bone. More...
Once high frequency, low amplitude ultrasonic energy is applied to liquefy the tip of the implant, PLDLLA flows into the bone cavities. Following cessation of the ultrasound pulse, the material re-solidifies and hardens, providing stable three-dimensional (3D) anchoring within five seconds.

The SonicAnchor is intended for suture or tissue fixation in foot, ankle, knee, hand, wrist, elbow, and shoulder open procedures. Examples include Achilles tendon repair, lateral and medial stabilization, hallux valgus reconstruction, midfoot reconstruction, metatarsal ligament repair, and digital tendon transfer. Even with its small, 2.5 mm diameter footprint, the SonicAnchor demonstrates significant enhancement in dynamic load stability, lower risk of breakage during insertion, and high pull out strength and reliability.

“Stryker is helping drive innovation in the industry with SonicAnchor and its unique fixation technology,” said orthopedic surgeon Adam Schiff, MD, of Loyola University Medical Center (Maywood, IL, USA), who has performed several procedures using the product. “Every time I place one, I am truly impressed by the strength and performance of this small implant.”

“SonicAnchor is transforming the soft tissue experience, and we are excited Stryker is leading the way in providing this innovative solution to orthopedic surgeons,” said Tom Popeck, vice president and general manager of Stryker's Foot and Ankle business unit. “SonicFusion technology is unlike any other on the market.”

Polylactide is biodegradable thermoplastic aliphatic polyester derived from renewable resources, such as cornstarch, tapioca roots, or sugarcane. It can be processed by extrusion, 3D printing, injection molding, film and sheet casting, and spinning, providing access to a wide range of products. Since it degrades into innocuous lactic acid, it is often used in surgery in the form of anchors, screws, plates, pins, rods, and as a mesh. Depending on the exact type used, it breaks down inside the body within 6 months to 2 years.

Related Links:
Stryker



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.